Severe RA and Coccidioidomycosis
RA patient complicated by invasive fungal infection with coccidioidomycosis is discussed by Drs. Tesser and Cush
Blogs
Off-Label Use – A Free Speech, Scientific and Safety Issue
Is off-label drug use an example of "free speech"? Do off-label use guidelines affect every day practice or the way Pharma promotes its product outside of the indications for which it was approved?
11 Pearls for Pregnancy Management in Rheumatoid Arthritis
Rheumatoid arthritis affects women in their child-bearing years and many will face the issue of pregnancy and RA management at some point. Here are11 considerations for those managing RA patients who wish to become pregnant.
TIPS for Arthritis Travelers
Travel can be challenging for arthritis patients. Here are some useful tips to travel smoothly and pain free.
Notes from the 2015 SPARTAN Meeting
Dr. Schwartzman reviews the proceedings of the 2015 Annual SPARTAN conference devoted to advances in spondyloarthritis.
How do you handle questions about sex?
I had just finished going over the prognosis and treatment plan with my newly diagnosed rheumatoid arthritis patient. I asked if she had any questions for me. She did.
An Elderly RA Patient with Hepatitis B and Latent TB
Comorbidities often influence the choice of therapies in RA. This elderly man with hepatitis and TB needs aggressive treatment, but what drugs can reasonably be considered?
Pick Up the Phone
Inefficient peer-to-peer physician communication has eroded integrated care and compromised patient outcomes and safety. Picking up the smart phone and use of technology may help to close these gaps.
Wine and the Rheumatologist
Wine and the rheumatologist in theory could be about a lot of things. Naturally, as rheumatologists, we are interested in how wine may affect rheumatic diseases. I am more inclined to write about how our community interacts around and enjoys wine.
Focus on Fatigue?
Fatigue is not far behind pain as the complaint that affects the quality of life in numerous rheumatic and autoimmune disorders. But do we need to focus on fatigue in our disease management?
Lupus Management After Failure of First-Line Treatment
There are no detailed recommendations agreed upon by SLE experts on what treatment to use after first and second (and often third) line treatment has failed.
Annual Review of Rheumatology Advances - 2014
This retrospective highlights several of the most impactful publications, trends, research and news that occurred in 2014.
